Vanguard Capital Management
IPSC icon

Vanguard Capital Management’s Century Therapeutics IPSC Stock Holding History

Vanguard Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
5,703,680
+17,476
+0.3% +$39.9K ﹤0.01% 2631
2026
Q1 		$12.9M Buy
+5,686,204
New +$12M ﹤0.01% 2593

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management's IPSC Position: Q2 2026 in Review

Vanguard Capital Management increased its Century Therapeutics (IPSC) stake by 0.31% in Q2 2026, buying an estimated $39.9K and bringing the position to 5,703,680 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Vanguard Capital Management first reported a position in IPSC in Q1 2026 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Vanguard Capital Management held 5,703,680 shares of Century Therapeutics worth $14M as of Q2 2026.
  • Vanguard Capital Management bought 17,476 Century Therapeutics shares in Q2 2026, an estimated $39.9K.
  • Century Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2631 holding.
  • Vanguard Capital Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.